1. Home
  2. JBSS vs MLYS Comparison

JBSS vs MLYS Comparison

Compare JBSS & MLYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JBSS
  • MLYS
  • Stock Information
  • Founded
  • JBSS 1959
  • MLYS 2019
  • Country
  • JBSS United States
  • MLYS United States
  • Employees
  • JBSS N/A
  • MLYS N/A
  • Industry
  • JBSS Specialty Foods
  • MLYS Biotechnology: Pharmaceutical Preparations
  • Sector
  • JBSS Consumer Staples
  • MLYS Health Care
  • Exchange
  • JBSS Nasdaq
  • MLYS Nasdaq
  • Market Cap
  • JBSS 814.9M
  • MLYS 893.0M
  • IPO Year
  • JBSS 1991
  • MLYS 2023
  • Fundamental
  • Price
  • JBSS $69.17
  • MLYS $14.00
  • Analyst Decision
  • JBSS
  • MLYS Strong Buy
  • Analyst Count
  • JBSS 0
  • MLYS 3
  • Target Price
  • JBSS N/A
  • MLYS $33.00
  • AVG Volume (30 Days)
  • JBSS 62.0K
  • MLYS 2.3M
  • Earning Date
  • JBSS 04-30-2025
  • MLYS 05-08-2025
  • Dividend Yield
  • JBSS 4.53%
  • MLYS N/A
  • EPS Growth
  • JBSS N/A
  • MLYS N/A
  • EPS
  • JBSS 4.16
  • MLYS N/A
  • Revenue
  • JBSS $1,118,719,000.00
  • MLYS N/A
  • Revenue This Year
  • JBSS N/A
  • MLYS N/A
  • Revenue Next Year
  • JBSS N/A
  • MLYS N/A
  • P/E Ratio
  • JBSS $16.95
  • MLYS N/A
  • Revenue Growth
  • JBSS 12.09
  • MLYS N/A
  • 52 Week Low
  • JBSS $68.46
  • MLYS $8.24
  • 52 Week High
  • JBSS $105.63
  • MLYS $18.38
  • Technical
  • Relative Strength Index (RSI)
  • JBSS 37.50
  • MLYS 50.95
  • Support Level
  • JBSS $68.94
  • MLYS $16.15
  • Resistance Level
  • JBSS $71.86
  • MLYS $17.17
  • Average True Range (ATR)
  • JBSS 1.25
  • MLYS 1.44
  • MACD
  • JBSS 0.14
  • MLYS -0.30
  • Stochastic Oscillator
  • JBSS 20.88
  • MLYS 18.59

About JBSS John B. Sanfilippo & Son Inc.

John B Sanfilippo & Son Inc is one of the processors and distributors of peanuts, pecans, cashews, walnuts, almonds, and other nuts in the United States. These nuts are sold under a variety of private brands and under the Fisher, Orchard Valley Harvest, and Sunshine Country brand names. It also market and distribute, and in the majority of cases, manufacture or process, a diverse product line of food and snack products, including peanut butter, almond butter, cashew butter, candy and confections, snacks and trail mixes, snack bites, sunflower kernels, dried fruit, corn snacks, sesame sticks and other sesame snack products under private brands and brand names.

About MLYS Mineralys Therapeutics Inc.

Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, typically including a diuretic.

Share on Social Networks: